CIK 0001831915 · Laboratory Analytical Instruments (SIC 3826) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|
| Revenue (USD) | 201.5 M | 164.0 M | ||
| Net income (USD) | -66.5 M | 2.5 M | ||
| Diluted EPS (USD/shares) | -0.09 | 0.1 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-09-29 | 8-K | 8-K items 5.03,9.01 | 2026-09-23 |
| 2026-09-02 | 144 | 144 | |
| 2026-08-24 | 8-K | 8-K items 7.01,8.01,9.01 | 2026-08-21 |
| 2026-08-20 | 4 | 4 | 2026-08-18 |
| 2026-08-20 | 4 | 4 | 2026-08-18 |
| 2026-08-20 | 4 | 4 | 2026-08-18 |
| 2026-08-20 | 4 | 4 | 2026-08-18 |
| 2026-08-20 | 4 | 4 | 2026-08-18 |
| 2026-08-20 | 4 | 4 | 2026-08-18 |
| 2026-08-12 | 4 | 4 | 2026-08-10 |
| 2026-08-06 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-05 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-05 | 8-K | 8-K items 2.02,9.01 | 2026-08-05 |
| 2026-08-04 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-07-15 | 8-K | 8-K items 5.02 | 2026-07-09 |
| 2026-07-08 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-06-30 | 3 | 3 | 2026-06-29 |
| 2026-06-25 | 8-K | 8-K items 5.02 | 2026-06-18 |
| 2026-06-16 | 4 | 4 | 2026-06-12 |
| 2026-06-16 | 8-K | 8-K items 5.07 | 2026-06-10 |
| 2026-06-12 | 4 | 4 | 2026-06-10 |
| 2026-06-12 | 4 | 4 | 2026-06-10 |
| 2026-06-12 | 3 | 3 | 2026-06-10 |
| 2026-06-12 | 4 | 4 | 2026-06-10 |
| 2026-06-12 | 4 | 4 | 2026-06-10 |
Forms on file (last 1,000): 4 272, 8-K 46, 3 21, 144 19, 10-Q 16, SCHEDULE 13G/A 11, SC 13G 9, SC 13G/A 9. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=CTKB (0.002 USD), /gw/filings/filings?ticker=CTKB&form=8-K, /gw/filings/facts?ticker=CTKB&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange